Cargando…
Inhibition of protein arginine methyltransferase 3 activity selectively impairs liver X receptor‐driven transcription of hepatic lipogenic genes in vivo
BACKGROUND AND PURPOSE: Agonists for the liver X receptor (LXR) are considered promising therapeutic moieties in cholesterol‐driven diseases by promoting cellular cholesterol efflux pathways. However, current clinical application of these agents is hampered by concomitant LXR‐induced activation of a...
Autores principales: | Nahon, Joya E, Groeneveldt, Christianne, Geerling, Janine J, van Eck, Miranda, Hoekstra, Menno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031883/ https://www.ncbi.nlm.nih.gov/pubmed/29774529 http://dx.doi.org/10.1111/bph.14361 |
Ejemplares similares
-
2-Hydroxypropyl-beta-cyclodextrin Treatment Does Not Induce Atherosclerotic Lesion Regression in Western-Type Diet-Fed Apolipoprotein E Knockout Mice
por: Snip, Olga S.C., et al.
Publicado: (2022) -
High-density lipoproteins and non-alcoholic fatty liver disease
por: Hoekstra, Menno, et al.
Publicado: (2023) -
Protein arginine methyltransferase 6 is a novel substrate of protein arginine methyltransferase 1
por: Cao, Meng-Tong, et al.
Publicado: (2023) -
Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma
por: Chaturvedi, Nagendra K., et al.
Publicado: (2019) -
Arginine methyltransferase inhibitor-1 inhibits sarcoma viability in vitro and in vivo
por: Zhang, Baolai, et al.
Publicado: (2018)